MATAURO’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.26M Buy
4,774
+169
+4% +$44.6K 0.16% 67
2026
Q2
$1.17M Buy
4,605
+70
+2% +$16.3K 0.15% 78
2026
Q1
$1.11M Sell
4,535
-224
-5% -$52.2K 0.16% 68
2025
Q4
$985K Buy
4,759
+45
+1% +$8.9K 0.15% 85
2025
Q3
$874K Buy
4,714
+177
+4% +$30.3K 0.14% 87
2025
Q2
$693K Sell
4,537
-733
-14% -$113K 0.13% 81
2025
Q1
$874K Buy
5,270
+3,345
+174% +$523K 0.18% 63
2024
Q4
$278K Buy
+1,925
New +$298K 0.06% 92

Other funds holding JNJ

MATAURO's JNJ Position: Q3 2026 in Review

MATAURO increased its Johnson & Johnson (JNJ) stake by 3.7% in Q3 2026, buying an estimated $44.6K and bringing the position to 4,774 shares worth $1.26M. The position accounts for 0.16% of the portfolio, ranked #67.

MATAURO first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 2,539 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • MATAURO held 4,774 shares of Johnson & Johnson worth $1.26M as of Q3 2026.
  • MATAURO bought 169 Johnson & Johnson shares in Q3 2026, an estimated $44.6K.
  • Johnson & Johnson made up 0.16% of MATAURO's portfolio in Q3 2026, its #67 holding.
  • MATAURO first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 2,539 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on MATAURO's 13F filing for Q3 2026, filed 3 Nov 2026.